Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (50.0%)Phase 4
1 (50.0%)Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
Phase 4
Recruiting
- Conditions
- HIV InfectionsHepatitis AImmunodeficiency
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- LiuZhou People's Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06576024
- Locations
- 🇨🇳
Liuzhou People's Hospital, Liuzhou, Guangxi, China
Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2020-03-16
- Lead Sponsor
- LiuZhou People's Hospital
- Target Recruit Count
- 204
- Registration Number
- NCT04309240
News
No news found